Max Sogaard
Overview
Explore the profile of Max Sogaard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
204
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Walker M, Idorn M, Bennett A, Sogaard M, Salanti A, Ditlev S, et al.
Immun Inflamm Dis
. 2023 Jun;
11(6):e910.
PMID: 37382252
Background: The development of vaccine candidates for COVID-19, and the administration of booster vaccines, has meant a significant reduction in COVID-19 related deaths world-wide and the easing of global restrictions....
2.
Walker M, Podlekareva D, Johnsen S, Leerhoy B, Fougeroux C, Sogaard M, et al.
Viruses
. 2022 Sep;
14(9).
PMID: 36146667
The development of vaccine candidates for COVID-19 has been rapid, and those that are currently approved display high efficacy against the original circulating strains. However, recently, new variants of severe...
3.
van Oosten L, Altenburg J, Fougeroux C, Geertsema C, van den End F, Evers W, et al.
mBio
. 2021 Oct;
12(5):e0181321.
PMID: 34634927
Vaccines pave the way out of the SARS-CoV-2 pandemic. Besides mRNA and adenoviral vector vaccines, effective protein-based vaccines are needed for immunization against current and emerging variants. We have developed...
4.
Bayarri-Olmos R, Idorn M, Rosbjerg A, Perez-Alos L, Hansen C, Johnsen L, et al.
J Immunol
. 2021 Jul;
207(3):878-887.
PMID: 34301847
Tools to monitor SARS-CoV-2 transmission and immune responses are needed. We present a neutralization ELISA to determine the levels of Ab-mediated virus neutralization and a preclinical model of focused immunization...
5.
Bagdonaite I, Thompson A, Wang X, Sogaard M, Fougeroux C, Frank M, et al.
Viruses
. 2021 Apr;
13(4).
PMID: 33806155
Enveloped viruses hijack not only the host translation processes, but also its glycosylation machinery, and to a variable extent cover viral surface proteins with tolerogenic host-like structures. SARS-CoV-2 surface protein...
6.
Bagdonaite I, Thompson A, Wang X, Sogaard M, Fougeroux C, Frank M, et al.
bioRxiv
. 2021 Feb;
PMID: 33564762
Enveloped viruses hijack not only the host translation processes, but also its glycosylation machinery, and to a variable extent cover viral surface proteins with tolerogenic host-like structures. SARS-CoV-2 surface protein...
7.
Fougeroux C, Goksoyr L, Idorn M, Soroka V, Myeni S, Dagil R, et al.
Nat Commun
. 2021 Jan;
12(1):324.
PMID: 33436573
The rapid development of a SARS-CoV-2 vaccine is a global priority. Here, we develop two capsid-like particle (CLP)-based vaccines displaying the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein. RBD...
8.
Bang-Christensen S, Pedersen R, Pereira M, Clausen T, Loppke C, Sand N, et al.
Cells
. 2019 Aug;
8(9).
PMID: 31466397
Diffuse gliomas are the most common primary malignant brain tumor. Although extracranial metastases are rarely observed, recent studies have shown the presence of circulating tumor cells (CTCs) in the blood...